logo
15:43 Feb 26

Themis Medicare Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
86.84
+4.34 (+5.26%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Themis Medicare Ltd. Financials

Themis Medicare Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
86.84
+4.34 (+5.26%)
15:43 Feb 26
Quality
image/svg+xml

50/100
Medium Financial Strength

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

29/100
Technically Bearish

Strength

7

Weakness

9

Opportunity

0

Threats

0

7.41 %

ROE %

5.07 %

ROA %

-1.89

EPS

43.74

BVPS

7.35 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
354.32 381.76 405.51 337.4
Operating Expenses +
286.88 330.25 356.46 346.59
Raw Material
126.16 138.28 149.98 129.86
Increase Decrease in Cost
-7.79 -1.57 -17.98 -3.53
Other Manufacturing Expense
0 0 0 0
Employee Cost
66.15 82.41 96.38 97.91
Miscellaneous Expenses
162.6 218.35 275.42 122.35
Operating Profit
67.44 51.51 49.05 -9.19
Other Income
11.5 4.76 4.67 7.25
Depreciation
10.49 12.25 9.93 10.24
Interest
9.56 9.38 10.04 10.43
Profit before tax and exceptio..
58.9 34.64 33.75 -22.61
Exceptional Items
0 0 0 -0.87
PBT
58.9 34.64 33.75 -21.74
Provision for Taxation
15.61 9.92 9.84 -0.85
Net Profit
43.28 24.72 23.91 -22.61
NET Profit after MI
56.9 43.52 29.83 -17.41
EPS
61.83 4.73 3.24 -1.88
Operating Profit Margin (%)
19.03 13.49 12.1 -2.72
Net Profit Margin (%)
16.06 11.4 7.36 -5.16

Themis Medicare Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 67.10 67.20 67.20 67.20 67.20 67.20
FII 0.00 0.10 0.10 0.10 0.10 0.10
Public 0.10 0.00 0.00 0.10 0.00 0.00
Others 32.80 32.70 32.70 32.60 32.70 32.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: